Skip to main content
NIH funding notice PAR-24-111

Understanding Mechanisms and Outcomes of Trained Immunity (R21 Clinical Trial Not Allowed)

Closed on May 23, 2025.

Posted
January 25, 2024
Close date
May 23, 2025
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $430,760 in first-year total cost, median $430,760.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 IIDA-B (90)]1

Most frequent institutions

  1. UNIVERSITY OF PITTSBURGH AT PITTSBURGH1
Competing awards under PAR-24-111 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Training of Neutrophils to Defend Against a Lethal Bacterial Infection of the Lung1R21AI193306-01RAY, PRABIRUNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA$430,760ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-24-111: Understanding Mechanisms and Outcomes of Trained Immunity (R21 Clinical Trial Not Allowed) | ScienceDex | ConductScience